Faron Pharmaceuticals Oy

LSE: FARN

Non-ownership Filings

Faron Pharmaceuticals Ltd: Faron appoints new CTO to strengthen late-stage development activities Mar. 26, 2026
FARON PHARMACEUTICALS LTD: HOLDING(S) IN COMPANY Mar. 24, 2026
FARON PHARMACEUTICALS LTD: HOLDING(S) IN COMPANY Mar. 12, 2026
The Finnish Financial Supervisory Authority has approved Faron's rights offering prospectus Mar. 11, 2026
FARON PHARMACEUTICALS LTD: HOLDING(S) IN COMPANY Mar. 11, 2026
Inside Information: Faron publishes the terms and conditions of a fully covered rights offering of approximately EUR 40 million and updates cash runway Mar. 10, 2026
Update to Faron’s Financial Calendar and date of the Annual General Meeting in 2026 Mar. 09, 2026

Ownership Update Filings

Faron Pharmaceuticals Ltd: Director Dealing Mar. 25, 2026
Faron Pharmaceuticals Ltd: Director Dealing Mar. 19, 2026
Faron Pharmaceuticals Ltd: Director Dealing Mar. 19, 2026
Faron Pharmaceuticals Ltd: Director Dealing Mar. 19, 2026
Holding(s) in Company Feb. 14, 2025
Holding(s) in Company Feb. 06, 2025
Grant of options Aug. 30, 2024